128
Participants
Start Date
October 10, 2024
Primary Completion Date
March 21, 2025
Study Completion Date
March 21, 2025
EnXtra® (300 mg) + Placebo (300 mg)
Two capsules to be taken after breakfast orally once a day (4 single doses in Acute stage and for 28 days in sub-acute stage)
Caffeine (200 mg) + Placebo (300 mg)
Two capsules to be taken after breakfast orally once a day (4 single doses in Acute stage and for 28 days in sub-acute stage)
EnXtra® (300 mg) + Caffeine (200 mg)
Two capsules to be taken after breakfast orally once a day (4 single doses in Acute stage and for 28 days in sub-acute stage)
Placebo (MCC 300 mg) + Placebo (300 mg)
Two capsules to be taken after breakfast orally once a day (4 single doses in Acute stage and for 28 days in sub-acute stage)
Gurukrupa Hospital, Thāne
Kalpana Hospital, Thāne
New Manak Healcare Hospital, Navi Mumbai
Enovate Biolife Pvt Ltd
INDUSTRY
Vedic Lifesciences Pvt. Ltd.
INDUSTRY